Concepedia

Robert Wilcox

RW

Statistics

Publications

7

Citations

911

H-Index

7

Active since

1997

Affiliations

Queen's Medical Centre(Current)

Thrombolysis in Myocardial Infarction Study Group

Takeda (United States)

Brigham and Women's Hospital

Robert Wilcox is an author at Queen's Medical Centre specializing in medicine, clinical pharmacology, and pharmacology.

Publications per year

1997–2014

7

Publications

7

Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous Stroke

Robert Wilcox, Marie‐Germaine Bousser, D. J. Betteridge et al. · Stroke · 2007 · 476 citations

, , +17

Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial

Benjamin M. Scirica, Marc P. Bonaca, Eugene Braunwald et al. · The Lancet · 2012 · 214 citations

, , +16

Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: Results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10)

Robert Wilcox, Stuart Kupfer, Erland Erdmann · American Heart Journal · 2008 · 132 citations

, , +15

Selection of reperfusion therapy for individual patients with evolving myocardial infarction

Frans van der Werf, A. Vahanian, Dietrich C. Gulba et al. · European Heart Journal · 1997 · 37 citations · Full text

, , +14

PAR-1 antagonist vorapaxar favorably improves global thrombotic status in patients with coronary disease

Gareth Rosser, Pierluigi Tricoci, David A. Morrow et al. · Journal of Thrombosis and Thrombolysis · 2014 · 19 citations

, , +12

1–5 of 7